NEOG
NEOG
US6404911066
Neogen Corporation
Loading chart...

Company Profile

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Latest News

Related stocks

TMDX
TMDX • United States
TransMedics Group, Inc.
77.87 USD
2.69B USD 1Y -33.1%
ALMR
ALMR • United States
Alamar Biosciences, Inc.
25.27 USD
1.75B USD
BFLY
BFLY • United States
Butterfly Network, Inc.
8.25 USD
2.2B USD 1Y +199.6%
IRTC
IRTC • United States
iRhythm Holdings, Inc.
106.7 USD
3.52B USD 1Y -42.7%
LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
TNDM
TNDM • United States
Tandem Diabetes Care, Inc.
16.11 USD
1.12B USD 1Y +2.2%
CBLL
CBLL • United States
CeriBell, Inc.
23.63 USD
906.87M USD 1Y +89.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
50.7% p.a.
Max Drawdown (5Y)
-90.6%
Sharpe Ratio (5Y)
-0.49
Beta Factor
1.79
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.79 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (56.8%) is noticeably higher than the 5Y average (50.7%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -90.9% in the extended horizon.
ende